LSERS
SCMP

Louisiana State Employees Retirement System’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Louisiana State Employees Retirement System’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,800
Closed -$194K – 1484
2017
Q4 		$194K Buy
10,800
+600
+6% +$7.39K 0.01% 1424
2017
Q3 		$120K Hold
10,200
– – 0.01% 1437
2017
Q2 		$107K Buy
10,200
+100
+1% +$1.02K 0.01% 1427
2017
Q1 		$111K Buy
+10,100
New +$117K 0.01% 1429

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Louisiana State Employees Retirement System's SCMP Position: Q1 2018 in Review

Louisiana State Employees Retirement System sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 10,800 shares — an estimated $194K sold.

Louisiana State Employees Retirement System first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $194K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Louisiana State Employees Retirement System reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 10,800 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $194K.
  • Louisiana State Employees Retirement System first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Louisiana State Employees Retirement System's Sucampo Pharmaceuticals, Inc. position peaked at $194K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Louisiana State Employees Retirement System's 13F filing for Q1 2018, filed 18 Apr 2018.